FROVATRIPTAN SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
When do Frovatriptan Succinate patents expire, and when can generic versions of Frovatriptan Succinate launch?
Frovatriptan Succinate is a drug marketed by Amneal Pharms Co, Glenmark Pharms Ltd, Leading, Pharmobedient, and Renata. and is included in five NDAs.
The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Frovatriptan Succinate
A generic version of FROVATRIPTAN SUCCINATE was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FROVATRIPTAN SUCCINATE?
- What are the global sales for FROVATRIPTAN SUCCINATE?
- What is Average Wholesale Price for FROVATRIPTAN SUCCINATE?
Summary for FROVATRIPTAN SUCCINATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Patent Applications: | 119 |
| What excipients (inactive ingredients) are in FROVATRIPTAN SUCCINATE? | FROVATRIPTAN SUCCINATE excipients list |
| DailyMed Link: | FROVATRIPTAN SUCCINATE at DailyMed |
Pharmacology for FROVATRIPTAN SUCCINATE
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FROVATRIPTAN SUCCINATE
Paragraph IV (Patent) Challenges for FROVATRIPTAN SUCCINATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| FROVA | Tablets | frovatriptan succinate | 2.5 mg | 021006 | 1 | 2011-03-09 |
US Patents and Regulatory Information for FROVATRIPTAN SUCCINATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Co | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 211292-001 | Nov 6, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 202931-001 | Aug 28, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glenmark Pharms Ltd | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 204730-001 | Mar 11, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Leading | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 216998-001 | Apr 16, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
